select between over 22,900 AI Tool and 17,900 AI News Posts.
Akeso, the Chinese biotechnology company whose drug ivonescimab was dubbed “biotech’s DeepSeek moment” last year, has reported phase three clinical trial results showing a 34% reduction in the risk of death for patients with advanced squamous non-small cell lung cancer. The data, filed with the Hong Kong stock exchange on Monday and selected for the American Society […]
This story continues at The Next Web